Company intelligence / Profile preview

Vapourtec

Bury Saint Edmunds, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

Vapourtec develops and manufactures laboratory-scale continuous flow chemistry systems and fast-flow solid phase peptide synthesizers used globally in pharmaceutical and biotech R&D for small-molecule and peptide synthesis; it does not develop its own therapeutics and therefore has no clinical pipeline.[2][4][3]

Modalities: Small moleculePeptides
Industry: Drug Discovery Services

Partnerships

Unspecified major pharmaceutical partner involved in software development for the Peptide-Builder peptide synthesizer[3]

Beyond the preview

Go deeper on Vapourtec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vapourtec.

Explore the full profile